Milrinone

CHEMBL189 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
211.2 g/mol
LogP
Phase
4

This medication strengthens heart contractions and relaxes blood vessels, helping the heart pump more effectively in acute heart failure. It is given intravenously in hospital settings and is not intended for long-term outpatient use.

น้ำหนักโมเลกุล

211.2200 g/mol

LogP

0.00

TPSA

65.80 Ų

Lipinski RO5

ผ่าน

ด้านการรักษา

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1

InChI

InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)

Molecular Formula

C12H9N3O

HBD / HBA

1 / 3

พันธะที่หมุนได้

1

อะตอมหนัก

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

This medication strengthens heart contractions and relaxes blood vessels, helping the heart pump more effectively in acute heart failure. It is given intravenously in hospital settings and is not intended for long-term outpatient use.

Yes, Milrinone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL189. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4197. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.